Cancer Profiling Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cancer Profiling Market?
The cancer profiling market is anticipated to expand due to the growing prevalence of cancer. The term “incidence of cancer” denotes the count of new cancer instances within a defined demographic during a set duration. The rising incidence of cancer can be attributed to urbanization, an expanding elderly populace, lifestyle modifications, and environmental and genetic influences. Cancer profiling facilitates the detection of specific molecular or genetic alterations in a tumor, like gene mutations or other changes in tumor DNA, which is instrumental to the cancer treatment process. For example, the American Cancer Society, a voluntary organization based in the U.S, projected in 2022 that there would be approximately 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the U.S. Consequently, the escalating incidence of cancer is propelling the growth of the cancer profiling market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp
#What Are the Key Projections for the CAGR of the Cancer Profiling Market From 2025 to 2034?
The market size for cancer profiling has significantly expanded in recent years. Projected growth indicates an increase from $13.48 billion in 2024 to $15.05 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this progression include an escalation in cancer diagnoses, the adoption of precision medicine methodologies, increased use of biomarkers in clinical settings, advances in drug development and targeted therapies, and a greater level of awareness and patient advocacy.
The market size for cancer profiling is set for a swift expansion in the forthcoming years, reaching a value of $23.08 billion in 2029 with a compound annual growth rate (CAGR) of 11.3%. Factors contributing to the expansion during the forecast period include the incorporation of artificial intelligence, worldwide research collaborations, widening use of liquid biopsy applications, regulatory backing for precision medicine, and a growing focus on early detection. Key trends in the forecast period comprise dominance of liquid biopsy, extensive genomic profiling, emergence of immunoprofiling, collaborative networks for data sharing, and single-cell sequencing.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912
What Are the Key Market Innovations in theCancer Profiling Market Over the Coming Years?
Predominant businesses in the cancer profiling market are honing in on advancements such as broad coverage. This form of testing investigates 517 genes pertinent to cancer across approximately 30 different types of solid tumors. Broad coverage signifies the extensive analyzes conducted on a myriad of genetic mutations, molecular targets, or biomarkers. For example, in March 2022, the American biotechnology firm Illumina, Inc. introduced the TruSight Oncology Comprehensive (TSO) test, paving new pathways in cancer diagnostics. This novel in vitro diagnostic test in Europe evaluates cancerous mutations to steer patients towards specific therapies. It encompasses 517 genes spanning almost 30 solid tumor types, scrutinizing both DNA and RNA. With results available within four to five days, this expedited process is approved by the CE marking for quality standards in Europe, minimizing the necessity for multiple gene tests on diverse tissue samples.
Who Are the Top Companies Driving Innovation and Growth in theCancer Profiling Market?
Major companies operating in the cancer profiling market include Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., Oncomine Dx Target Test, OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Which Key Market Segments Comprise the Cancer Profiling Market and Drive Its Revenue Growth?
The cancer profiling market covered in this report is segmented –
1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization
2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers
4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications
Subsegments:
1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology, Radioimmunoassays
2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)
3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)
4) By Microarrays: DNA Microarrays, RNA Microarrays, SNP Arrays
5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9912&type=smpGlobal Cancer Profiling Market, Global Cancer Profiling Market Report, Global Cancer Profiling Market Trends, Global Cancer Profiling Market Size
Browse Through More Reports Similar to the Gobal Cancer Profiling Maret 2025, By The Business Research Company:
Pain Management Devices And Therapies Global Market Report 2024
Skin Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
